DEINOVE Appoints Alexis Rideau as CEO, Effective May 1, 2020
May 04, 2020 at 02:30 am EDT
DEINOVE, announced the appointment of Alexis RIDEAU as CEO, effective May 1, 2020. Prior to joining DEINOVE, Alexis RIDEAU was in charge of developing industrial relations and coordinating the strategic partnership team at BIOASTER. Alexis RIDEAU has been directly involved in the definition and implementation of the Institute's technology and economic strategy, as well as the valorization of platforms in the industrial sectors of microbiota, antimicrobials, vaccines and diagnostic. He initiated and implemented structuring partnerships, technologically and financially.